Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Evaluation of the molecular bacterial load assay for detecting viable Mycobacterium tuberculosis in cerebrospinal fluid before and during tuberculous meningitis treatment.

Hai HT. et al, (2021), Tuberculosis (Edinburgh, Scotland), 128

Most-Probable-Number-Based Minimum Duration of Killing Assay for Determining the Spectrum of Rifampicin Susceptibility in Clinical Mycobacterium tuberculosis Isolates.

Vijay S. et al, (2021), Antimicrobial agents and chemotherapy, 65

Sources of Multidrug Resistance in Patients With Previous Isoniazid-Resistant Tuberculosis Identified Using Whole Genome Sequencing: A Longitudinal Cohort Study

Srinivasan V. et al, (2020), Clinical Infectious Diseases, 71, e532 - e539

Xpert MTB/RIF Ultra versus Xpert MTB/RIF for the diagnosis of tuberculous meningitis: a prospective, randomised, diagnostic accuracy study.

Donovan J. et al, (2020), The Lancet. Infectious diseases, 20, 299 - 307

Risk factors for poor treatment outcomes of 2266 multidrug-resistant tuberculosis cases in Ho Chi Minh City: a retrospective study.

Van LH. et al, (2020), BMC infectious diseases, 20

Development of ligand‐coated beads to measure macrophage antimicrobial activities

Tram TTB. et al, (2019), Biology of the Cell, 111, 262 - 270

Do Intracerebral Cytokine Responses Explain the Harmful Effects of Dexamethasone in Human Immunodeficiency Virus–associated Cryptococcal Meningitis?

Beardsley J. et al, (2019), Clinical Infectious Diseases, 68, 1494 - 1501

Pretreatment Cerebrospinal Fluid Bacterial Load Correlates With Inflammatory Response and Predicts Neurological Events During Tuberculous Meningitis Treatment

Thuong NTT. et al, (2019), The Journal of Infectious Diseases, 219, 986 - 995

Increasing women's leadership in science in Ho Chi Minh City.

Hoa NT. et al, (2019), Lancet (London, England), 393, 523 - 524

Bacterial risk factors for treatment failure and relapse among patients with isoniazid resistant tuberculosis

Thai PVK. et al, (2018), BMC Infectious Diseases, 18

Improving the microbiological diagnosis of tuberculous meningitis: A prospective, international, multicentre comparison of conventional and modified Ziehl–Neelsen stain, GeneXpert, and culture of cerebrospinal fluid

Heemskerk AD. et al, (2018), Journal of Infection, 77, 509 - 515

Modeling tuberculosis dynamics with the presence of hyper-susceptible individuals for Ho Chi Minh City from 1996 to 2015

Vinh DN. et al, (2018), BMC Infectious Diseases, 18

Virulence of Mycobacterium tuberculosis Clinical Isolates Is Associated With Sputum Pre-treatment Bacterial Load, Lineage, Survival in Macrophages, and Cytokine Response

Tram TTB. et al, (2018), Frontiers in Cellular and Infection Microbiology, 8

Adjunctive dexamethasone for the treatment of HIV-infected adults with tuberculous meningitis (ACT HIV): Study protocol for a randomised controlled trial

Donovan J. et al, (2018), Wellcome Open Research, 3, 31 - 31

Frequent transmission of the Mycobacterium tuberculosis Beijing lineage and positive selection for the EsxW Beijing variant in Vietnam

Holt KE. et al, (2018), Nature Genetics, 50, 849 - 856

Adjunctive dexamethasone for the treatment of HIV-infected adults with tuberculous meningitis (ACT HIV): Study protocol for a randomised controlled trial

Donovan J. et al, (2018), Wellcome Open Research, 3, 31 - 31

Adjunctive dexamethasone for the treatment of HIV-uninfected adults with tuberculous meningitis stratified by Leukotriene A4 hydrolase genotype (LAST ACT): Study protocol for a randomised double blind placebo controlled non-inferiority trial

Donovan J. et al, (2018), Wellcome Open Research, 3, 32 - 32

A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults

Mai NTH. et al, (2018), eLife, 7

Prognostic Models for 9-Month Mortality in Tuberculous Meningitis

Thao LTP. et al, (2018), Clinical Infectious Diseases, 66, 523 - 532

Ultrastructural Analysis of Cell Envelope and Accumulation of Lipid Inclusions in Clinical Mycobacterium tuberculosis Isolates from Sputum, Oxidative Stress, and Iron Deficiency

Vijay S. et al, (2018), Frontiers in Microbiology, 8

Load More

Include forthcoming?